0 0 0 0 0 0 0 0
Sign Up Today X
Thanks for submitting the form.
Stockreport

Is Regeneron Pharmaceuticals, Inc. (REGN) A Good Stock To Buy? [Yahoo! Finance]

Regeneron Pharmaceuticals, Inc. (REGN)  More Company Research Source: Yahoo! Finance
Last regeneron pharmaceuticals, inc. earnings: 2/6 06:30 am Check Earnings Report
US:NASDAQ Investor Relations: investor.regeneron.com
In this article, we will summarize the bulls' thesis on REGN. Regeneron Pharmaceuticals, Inc.'s share was trading at $774.66 as of March 11th. REGN's trailing and forward P/E were 18.68 and 18.05, respectively according to Yahoo Finance. Nestor Rizhniak/Shutterstock.com Regeneron Pharmaceuticals, Inc. (REGN) stands out as a powerful innovation engine within the biopharmaceutical industry, driven by strong foundational science and a proven ability to commercialize breakthrough therapies. At the center of its growth story is Dupixent, a blockbuster drug that has rapidly become one of the most successful treatments in modern medicine. Originally approved for atopic dermatitis, Dupixent has expanded into additional indications such as asthma and other inflammatory diseases, demonstrating exceptional efficacy and a widening patient base. The drug is widely expected to become one of the best-selling pharmaceuticals of all time, generating significant and recurring revenue for the comp [Read more]
IMPACT SNAPSHOT EVENT TIME: REGN
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
 POST NEWS RANGE
%
PRICE CHANGE
PRICE CHANGE PERCENTAGE
S&P 500 (SPX)
%
 VOLUME RATIO
%
VOLUME (SHARES)
TICKS
AVG SHARES PER TRADE
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
REGN alerts
from News Quantified
REGN
NEWS
REGN
Earnings
REGN
Analyst Actions
REGN
SEC Filings
Stockreport

Is Regeneron Pharmaceuticals, Inc. (REGN) A Good Stock To Buy? [Yahoo! Finance]

Regeneron Pharmaceuticals, Inc.  (REGN) 
More Company Research Source: Yahoo! Finance
Last regeneron pharmaceuticals, inc. earnings: 2/6 06:30 am Check Earnings Report
US:NASDAQ Investor Relations: investor.regeneron.com
In this article, we will summarize the bulls' thesis on REGN. Regeneron Pharmaceuticals, Inc.'s share was trading at $774.66 as of March 11th. REGN's trailing and forward P/E were 18.68 and 18.05, respectively according to Yahoo Finance. Nestor Rizhniak/Shutterstock.com Regeneron Pharmaceuticals, Inc. (REGN) stands out as a powerful innovation engine within the biopharmaceutical industry, driven by strong foundational science and a proven ability to commercialize breakthrough therapies. At the center of its growth story is Dupixent, a blockbuster drug that has rapidly become one of the most successful treatments in modern medicine. Originally approved for atopic dermatitis, Dupixent has expanded into additional indications such as asthma and other inflammatory diseases, demonstrating exceptional efficacy and a widening patient base. The drug is widely expected to become one of the best-selling pharmaceuticals of all time, generating significant and recurring revenue for the comp [Read more]
IMPACT SNAPSHOT
EVENT TIME:
REGN
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Don't Miss Out On The Next BIG Stock Move
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
 POST NEWS RANGE
%
PRICE CHANGE
PRICE CHANGE PERCENTAGE
S&P 500 (SPX)
%
 VOLUME RATIO
%
VOLUME (SHARES)
TICKS
AVG SHARES PER TRADE
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS